Bile Duct Cancer: New Molecular Test Doubles Detection Rate

A new molecular test, BiliSeq, developed by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine, is poised to significantly improve the early and accurate diagnosis of bile duct cancer – a malignancy historically plagued by diagnostic delays and inaccuracies. This isn’t simply an incremental improvement; the test nearly doubles … Read more

Bile Duct Cancer: Highly Sensitive Molecular Test Found

For patients facing the agonizing uncertainty of potential bile duct cancer, a new molecular test, BiliSeq, offers a significant leap forward in diagnostic accuracy and personalized treatment planning. Published in Gastroenterology, the test demonstrates a crucial ability to detect cancers often missed by traditional methods, addressing a long-standing clinical challenge where a negative biopsy doesn’t … Read more